Robert A Seiser - Net Worth and Insider Trading

Robert A Seiser Net Worth

The estimated net worth of Robert A Seiser is at least $8,868 dollars as of 2024-06-23. Robert A Seiser is the VP, Controller & Treasurer of Acura Pharmaceuticals Inc and owns about 322,490 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $8,868. Details can be seen in Robert A Seiser's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert A Seiser has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).

Transaction Summary of Robert A Seiser

To

Robert A Seiser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert A Seiser owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .

Click here to see the complete history of Robert A Seiser’s form 4 insider trades.

Insider Ownership Summary of Robert A Seiser

Ticker Comapny Transaction Date Type of Owner
ACUR Acura Pharmaceuticals Inc 2020-01-02 VP & Treasurer & Controller

Robert A Seiser Latest Holdings Summary

Robert A Seiser currently owns a total of 1 stock. Robert A Seiser owns 322,490 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $8,868.

Latest Holdings of Robert A Seiser

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACUR Acura Pharmaceuticals Inc 2017-12-14 322,490 0.03 8,868

Holding Weightings of Robert A Seiser


Robert A Seiser Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert A Seiser has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 300,000 shares on December 14, 2017, which cost Robert A Seiser around $30,000.

Insider Trading History of Robert A Seiser

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert A Seiser Trading Performance

GuruFocus tracks the stock performance after each of Robert A Seiser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert A Seiser is 67.65%. GuruFocus also compares Robert A Seiser's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert A Seiser within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert A Seiser's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert A Seiser

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 58.82 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 53.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Robert A Seiser Ownership Network

Ownership Network List of Robert A Seiser

No Data

Ownership Network Relation of Robert A Seiser

Insider Network Chart

Robert A Seiser Owned Company Details

What does Acura Pharmaceuticals Inc do?

Who are the key executives at Acura Pharmaceuticals Inc?

Robert A Seiser is the VP & Treasurer & Controller of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , President & CEO Robert B Jones , and VP Pharmaceutical Sciences APT Albert W Brzeczko .

Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acura Pharmaceuticals Inc Insider Transactions

No Available Data

Robert A Seiser Mailing Address

Above is the net worth, insider trading, and ownership report for Robert A Seiser. You might contact Robert A Seiser via mailing address: C/o Acura Pharmaceuticals, Inc. 616 N. North Court Suite 120 Palatine Il 60067.

Discussions on Robert A Seiser

No discussions yet.